1.Prevalence of SARS-CoV-2 infection among urban cleaning and solid waste management workers during transmission of the Omicron variant in Brazil
Paulo Ricardo MARTINS-FILHO ; Joyce Thayane da Conceição DOS SANTOS ; Márcia Santos REZENDE ; Fernanda Oliveira DE CARVALHO ; Érica Santos DOS REIS ; Waneska de Souza BARBOZA ; Taise Ferreira CAVALCANTE ; Cliomar Alves DOS SANTOS ; Lucindo José QUINTANS-JÚNIOR ; Renata GRESPAN ; Cristiane Bani CORRÊA ; Tatiana Rodrigues DE MOURA ; Dulce Marta SCHIMIEGUEL ; Jullyana de Souza Siqueira QUINTANS ; Adriano Antunes DE SOUZA ARAÚJO
Epidemiology and Health 2023;45(1):e2023025-
This study estimated the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in urban cleaning and solid waste management workers during the transmission of the Omicron variant in one of the poorest regions of Brazil (the state of Sergipe). Nasopharyngeal swabs were collected from 494 workers, and the presence of SARS-CoV-2 RNA was tested by quantitative reverse-transcriptase polymerase chain reaction. Data on socio-demographic characteristics, comorbidities, vaccination status, mask use, and use of public transport to commute to the workplace were collected. The prevalence with a 95% confidence interval (CI) was calculated from the proportion of SARS-CoV-2 positive cases among the total number of individuals tested. The prevalence ratio (PR) with a 95% CI was the measure of association used to evaluate the relationship between SARS-CoV-2 infection and the exposure variables. The prevalence of SARS-CoV-2 infection was 22.5% (95% CI, 19.0 to 26.4). Individuals under the age of 40 had a higher prevalence of infection (PR, 1.53; 95% CI, 1.03 to 2.30) as well as those who did not believe in the protective effect of vaccines (PR, 1.78; 95% CI, 1.05 to 2.89). Our results indicate the need for better guidance on preventive measures against coronavirus disease 2019 among urban cleaning and solid waste management workers.
2.Miller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection:A Systematic Review
Paulo Ricardo MARTINS-FILHO ; Ana Luiza Pereira DE ANDRADE ; Ana Júlia Pereira DE ANDRADE ; Maria Daniella MOURA DA SILVA ; Adriano Antunes de SOUZA ARAÚJO ; Paula Santos NUNES ; Victor Santana SANTOS ; Lis Campos FERREIRA ; Eduardo Luis de AQUINO NEVES ; Lucindo José QUINTANS-JÚNIOR
Journal of Clinical Neurology 2021;17(4):541-545
Background:
and PurposeMiller Fisher syndrome (MFS) is a subtype of Guillain-Barré syndrome characterized by the triad of ophthalmoparesis, areflexia, and ataxia. Although cases of MFS have been associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, no studies have synthesized the clinical characteristics of patients with this condition.
Methods:
In this rapid systematic review, we searched the PubMed database to identify studies on MFS associated with SARS-CoV-2 infection.
Results:
This review identified 11 cases, of whom 3 were hospitalized with motor and/or sensory polyneuropathy as the first sign of SARS-CoV-2 infection. SARS-CoV-2 RNA was not detected in analyses of cerebrospinal fluid, suggesting a mechanism of immune-mediated injury rather than direct viral neurotropism. However, antiganglioside antibodies were found in only two of the nine patients tested. It is possible that target antigens other than gangliosides are involved in MFS associated with SARS-CoV-2 infection.
Conclusions
The present patients exhibited clinical improvement after being treated with intravenous immunoglobulin. Although rare, patients with SARS-CoV-2 infection may present neurological symptoms suggestive of MFS. Early recognition of the MFS clinical triad is essential for the timely initiation of treatment.
3.Miller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection:A Systematic Review
Paulo Ricardo MARTINS-FILHO ; Ana Luiza Pereira DE ANDRADE ; Ana Júlia Pereira DE ANDRADE ; Maria Daniella MOURA DA SILVA ; Adriano Antunes de SOUZA ARAÚJO ; Paula Santos NUNES ; Victor Santana SANTOS ; Lis Campos FERREIRA ; Eduardo Luis de AQUINO NEVES ; Lucindo José QUINTANS-JÚNIOR
Journal of Clinical Neurology 2021;17(4):541-545
Background:
and PurposeMiller Fisher syndrome (MFS) is a subtype of Guillain-Barré syndrome characterized by the triad of ophthalmoparesis, areflexia, and ataxia. Although cases of MFS have been associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, no studies have synthesized the clinical characteristics of patients with this condition.
Methods:
In this rapid systematic review, we searched the PubMed database to identify studies on MFS associated with SARS-CoV-2 infection.
Results:
This review identified 11 cases, of whom 3 were hospitalized with motor and/or sensory polyneuropathy as the first sign of SARS-CoV-2 infection. SARS-CoV-2 RNA was not detected in analyses of cerebrospinal fluid, suggesting a mechanism of immune-mediated injury rather than direct viral neurotropism. However, antiganglioside antibodies were found in only two of the nine patients tested. It is possible that target antigens other than gangliosides are involved in MFS associated with SARS-CoV-2 infection.
Conclusions
The present patients exhibited clinical improvement after being treated with intravenous immunoglobulin. Although rare, patients with SARS-CoV-2 infection may present neurological symptoms suggestive of MFS. Early recognition of the MFS clinical triad is essential for the timely initiation of treatment.